These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
907 related articles for article (PubMed ID: 27180559)
1. Long-term follow-up of pediatric moyamoya disease treated by combined direct-indirect revascularization surgery: single institute experience with surgical and perioperative management. Rashad S; Fujimura M; Niizuma K; Endo H; Tominaga T Neurosurg Rev; 2016 Oct; 39(4):615-23. PubMed ID: 27180559 [TBL] [Abstract][Full Text] [Related]
2. "STA-MCA bypass with encephalo-duro-myo-synangiosis combined with bifrontal encephalo-duro-periosteal-synangiosis" as a one-staged revascularization strategy for pediatric moyamoya vasculopathy. Esposito G; Kronenburg A; Fierstra J; Braun KP; Klijn CJ; van der Zwan A; Regli L Childs Nerv Syst; 2015 May; 31(5):765-72. PubMed ID: 25722049 [TBL] [Abstract][Full Text] [Related]
3. Superficial temporal artery-to-middle cerebral artery bypass in combination with indirect revascularization in moyamoya patients ≤ 3 years of age. Bot GM; Burkhardt JK; Gupta N; Lawton MT J Neurosurg Pediatr; 2019 Feb; 23(2):198-203. PubMed ID: 30497164 [TBL] [Abstract][Full Text] [Related]
4. The importance of encephalo-myo-synangiosis in surgical revascularization strategies for moyamoya disease in children and adults. Imai H; Miyawaki S; Ono H; Nakatomi H; Yoshimoto Y; Saito N World Neurosurg; 2015 May; 83(5):691-9. PubMed ID: 25655688 [TBL] [Abstract][Full Text] [Related]
5. Significance of Quantitative Cerebral Blood Flow Measurement in the Acute Stage after Revascularization Surgery for Adult Moyamoya Disease: Implication for the Pathological Threshold of Local Cerebral Hyperperfusion. Kameyama M; Fujimura M; Tashiro R; Sato K; Endo H; Niizuma K; Mugikura S; Tominaga T Cerebrovasc Dis; 2019; 48(3-6):217-225. PubMed ID: 31812964 [TBL] [Abstract][Full Text] [Related]
6. Late (5-20 years) outcomes after STA-MCA anastomosis and encephalo-duro-myo-arterio-pericranial synangiosis in patients with moyamoya disease. Kuroda S; Nakayama N; Yamamoto S; Kashiwazaki D; Uchino H; Saito H; Hori E; Akioka N; Kuwayama N; Houkin K J Neurosurg; 2021 Mar; 134(3):909-916. PubMed ID: 32168480 [TBL] [Abstract][Full Text] [Related]
7. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. Fujimura M; Mugikura S; Kaneta T; Shimizu H; Tominaga T Surg Neurol; 2009 Apr; 71(4):442-7. PubMed ID: 18514264 [TBL] [Abstract][Full Text] [Related]
8. Incidence and Risk Factors of the Watershed Shift Phenomenon after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis for Adult Moyamoya Disease. Tashiro R; Fujimura M; Kameyama M; Mugikura S; Endo H; Takeuchi Y; Tomata Y; Niizuma K; Tominaga T Cerebrovasc Dis; 2019; 47(3-4):178-187. PubMed ID: 31121577 [TBL] [Abstract][Full Text] [Related]
9. Ameliorative Effects of Combined Revascularization Surgery on Abnormal Collateral Channels in Moyamoya Disease. Yamamoto S; Kashiwazaki D; Uchino H; Saito H; Hori E; Akioka N; Kuwayama N; Kuroda S J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105624. PubMed ID: 33516067 [TBL] [Abstract][Full Text] [Related]
10. Superficial temporal artery-middle cerebral artery bypass combined with encephalo-duro-myo-synangiosis in treating moyamoya disease: surgical techniques, indications and midterm follow-up results. Xu B; Song DL; Mao Y; Gu YX; Xu H; Liao YJ; Liu CH; Zhou LF Chin Med J (Engl); 2012 Dec; 125(24):4398-405. PubMed ID: 23253709 [TBL] [Abstract][Full Text] [Related]
11. Bypass surgery for moyamoya disease: concept and essence of sugical techniques. Kuroda S; Houkin K Neurol Med Chir (Tokyo); 2012; 52(5):287-94. PubMed ID: 22688064 [TBL] [Abstract][Full Text] [Related]
12. Novel bypass surgery for moyamoya disease using pericranial flap: its impacts on cerebral hemodynamics and long-term outcome. Kuroda S; Houkin K; Ishikawa T; Nakayama N; Iwasaki Y Neurosurgery; 2010 Jun; 66(6):1093-101; discussion 1101. PubMed ID: 20495424 [TBL] [Abstract][Full Text] [Related]
13. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults. Jang DK; Lee KS; Rha HK; Huh PW; Yang JH; Park IS; Ahn JG; Sung JH; Han YM J Neurosurg; 2017 Sep; 127(3):492-502. PubMed ID: 27834597 [TBL] [Abstract][Full Text] [Related]
14. Minocycline prevents focal neurological deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease. Fujimura M; Niizuma K; Inoue T; Sato K; Endo H; Shimizu H; Tominaga T Neurosurgery; 2014 Feb; 74(2):163-70; discussion 170. PubMed ID: 24176958 [TBL] [Abstract][Full Text] [Related]
16. Navigation-guided clipping of a de novo aneurysm associated with superficial temporal artery-middle cerebral artery bypass combined with indirect pial synangiosis in a patient with moyamoya disease. Aburakawa D; Fujimura M; Niizuma K; Sakata H; Endo H; Tominaga T Neurosurg Rev; 2017 Jul; 40(3):517-521. PubMed ID: 28555327 [TBL] [Abstract][Full Text] [Related]
17. Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease. Fujimura M; Kaneta T; Mugikura S; Shimizu H; Tominaga T Surg Neurol; 2007 Mar; 67(3):273-82. PubMed ID: 17320638 [TBL] [Abstract][Full Text] [Related]
18. Superficial temporal artery-to-middle cerebral artery anastomosis with encephalo-duro-myo-synangiosis as a modified operative procedure for moyamoya disease. Ishii K; Morishige M; Anan M; Sugita K; Abe E; Kubo T; Fujiki M; Kobayashi H Acta Neurochir Suppl; 2010; 107():95-9. PubMed ID: 19953378 [TBL] [Abstract][Full Text] [Related]
19. Correlation between reduction in microvascular transit time after superficial temporal artery-middle cerebral artery bypass surgery for moyamoya disease and the development of postoperative hyperperfusion syndrome. Yang T; Higashino Y; Kataoka H; Hamano E; Maruyama D; Iihara K; Takahashi JC J Neurosurg; 2018 May; 128(5):1304-1310. PubMed ID: 28498060 [TBL] [Abstract][Full Text] [Related]
20. Enlarged Encephalo-Duro-Myo-Synangiosis Treatment for Moyamoya Disease in Young Children. Shen W; Xu B; Li H; Gao X; Liao Y; Shi W; Zhao R; Zhang Y World Neurosurg; 2017 Oct; 106():9-16. PubMed ID: 28645592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]